Search

everythinglearnresearchcommunity

for

Search:↓

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

The dual-wavelength laser system effectively reduces EFFC symptoms with minimal side effects.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Epidermolysis bullosa in UK calves is not caused by mutations in keratin genes.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Kūlaris improved quality of life for acne sufferers without side effects.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Lokivetmab reduced itching in a dog with skin lymphoma.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

The FUE-LE technique combines two hair transplant methods to harvest more hair with minimal visible scarring, especially for patients with advanced hair loss.

Pix Liquida helped a man recover from patchy hair loss.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.